Investigational Site Number 4003

New York, New York 10032

0 studies enrolling now · 1 studies all time

What they study most

Primary Focal Segmental Glomerulosclerosis

Studies at this site

• A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) — Completed